Monopar Therapeutics  logo
Monopar Therapeutics MNPR
$ 26.12 9.79%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Monopar Therapeutics EV/EBITDA Ratio 2011-2024 | MNPR

Annual EV/EBITDA Ratio Monopar Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.05 -11.6 -33.2 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.05 -33.2 -15.6